Hepatocellular carcinoma (HCC) recurrence and what to do when it happens
As we know, gold standard therapy for hepatocellular carcinoma (HCC) with underlying liver disease is orthotopic liver transplantation (OLT) given that the malignant burden is within certain criteria. Prior to 1996, outcomes were quite poor with 5-year survival reported as low as 20% (1) with transplants being performed without impedance for all tumors of all sizes.
5
2019-07-18(万方平台首次上网日期,不代表论文的发表时间)
共3页
503-505